Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Association of C-reactive protein with efficacy of avelumab plus axitinib in advanced renal cell carcinoma: long-term follow-up results from JAVELIN Renal 101ESMO Open 2022 Aug 26;7(5)100564, Y Tomita, J Larkin, B Venugopal, J Haanen, H Kanayama, M Eto, MO Grimm, Y Fujii, Y Umeyama, B Huang, M Mariani, A di Pietro, TK Choueiri
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.